|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Roivant Sciences, Inc.
| | | Phone: | (212) 847-6204 | Year Established: | 2014 | Main Contact: | Alan Roemer, MBA, MPH, Senior VP, Corporate Development | | Other Contacts: | Dan Rothman, CIO Matthew Gline, CFO Mayukh Sukhatme, M.D., CBO William T. Symonds, Pharm.D., Chief Development Officer Lawrence T. Friedhoff, M.D., Ph.D., Chief of R&D Vivek Ramaswamy, Founder, President & CEO
| | Company Description | Roivant is dedicated to transformative innovation in healthcare. Roivant focuses on realizing the full potential of promising biomedical research by developing and commercializing novel therapies across diverse therapeutic areas. Roivant partners with innovative biopharmaceutical companies and academic institutions to ensure that important medicines are rapidly developed and delivered to patients. Roivant advances its drug pipelines through wholly- or majority-owned subsidiary companies, including Axovant (neurology), Myovant (women’s health and endocrine diseases), Dermavant (dermatology), Enzyvant (rare diseases), and Urovant (urology). Roivant also plans to launch new companies operating outside of traditional biopharmaceutical development. Roivant’s long-range mission is to reduce the time and cost of developing and delivering new medicines for patients. | |
|
|
|
|
|